Comparative tolerability of treatments for inflammatory bowel disease

Despite limited understanding of therapeutic aetiopathogenesis of ulcerative colitis and Crohn's disease, there is a strong evidence base for the efficacy of pharmacological and biological therapies. It is equally important to recognise toxicity of the medical armamentarium for inflammatory bow...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2000, Vol.23 (5), p.429-448
Hauptverfasser:	STEIN, Robert B, HANAUER, Stephen B
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - adverse effects Adrenal Cortex Hormones - pharmacology Adrenal Cortex Hormones - therapeutic use Anti-Infective Agents - adverse effects Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - pharmacology Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Biological and medical sciences corticoids Drug toxicity and drugs side effects treatment Female Gastrointestinal Agents - adverse effects Gastrointestinal Agents - pharmacology Gastrointestinal Agents - therapeutic use Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - pharmacology Immunosuppressive Agents - therapeutic use inflammatory bowel disease Inflammatory Bowel Diseases - drug therapy Male Medical sciences Mesalamine - adverse effects Mesalamine - pharmacology Mesalamine - therapeutic use Miscellaneous (drug allergy, mutagens, teratogens...) olsalazine Pharmacology. Drug treatments Pregnancy Prodrugs - metabolism sulfapyridine Sulfasalazine - adverse effects Sulfasalazine - pharmacology Sulfasalazine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!